Fabio
5.5 KiB
5.5 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Opioids; providers of treatment for addiction, conditions for initial licensure, location. | Providers of treatment for persons with opiate addiction; elimination of location restriction. Eliminates the requirement that a provider of treatment for persons with opiate addiction through the use of (i) methadone or (ii) opioid replacements other than opioid replacements approved for the treatment of opioid addiction by the U.S. Food and Drug Administration be located more than one-half mile from a public or private licensed day care center or a public or private K-12 school. This bill has a delayed effective date of January 1, 2023, and is identical to HB 679. | us/states/va | Virginia General Assembly | 2022 | SB 300 | Virginia SB 300 (2022) |
|
enacted |
|
4 | 31 | 6 | 2022-01-11 | 2022-04-11 | openstates | ocd-bill/61d040ec-9222-4d8d-a46f-6d3ed9e63f7f | https://lis.virginia.gov/cgi-bin/legp604.exe?221+sum+SB300 | d9bf30edddded6381e3721d49977f0ed131e4fc1a66ab2247bc80901c31fc0bf | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia SB 300 (2022) — Opioids; providers of treatment for addiction, conditions for initial licensure, location.
Providers of treatment for persons with opiate addiction; elimination of location restriction. Eliminates the requirement that a provider of treatment for persons with opiate addiction through the use of (i) methadone or (ii) opioid replacements other than opioid replacements approved for the treatment of opioid addiction by the U.S. Food and Drug Administration be located more than one-half mile from a public or private licensed day care center or a public or private K-12 school. This bill has a delayed effective date of January 1, 2023, and is identical to HB 679.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- CHAP0513 (committee substitute) — source
- Committee substitute printed 22106839D-H1 (committee substitute) — source
- Prefiled and ordered printed; offered 01/12/22 22102027D (committee substitute) — source
- SB300ER (committee substitute) — source
Votes
- Reported from Education and Health (13-Y 1-N 1-A) — 13–1 (pass) · upper
- Constitutional reading dispensed (37-Y 0-N) — 37–0 (pass) · upper
- Reported from Health, Welfare and Institutions with substitute (20-Y 1-N) — 20–1 (pass) · lower
- House substitute agreed to by Senate (39-Y 0-N) — 39–0 (pass) · upper
- VOTE: Passage (100-Y 0-N) — 99–0 (pass) · lower
- Read third time and passed Senate (27-Y 11-N) — 27–11 (pass) · upper
Sponsors
- R. Creigh Deeds — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2022-01-11 Prefiled and ordered printed; offered 01/12/22 22102027D
introduction - 2022-01-11 Referred to Committee on Education and Health
referral-committee - 2022-01-13 Assigned Education sub: Health Professions
referral-committee - 2022-01-20 Reported from Education and Health (13-Y 1-N 1-A)
committee-passage - 2022-01-21 Constitutional reading dispensed (37-Y 0-N)
- 2022-01-24 Read second time and engrossed
reading-2 - 2022-01-24 Impact statement from DPB (SB300)
- 2022-01-25 Passed by for the day
- 2022-01-26 Read third time and passed Senate (27-Y 11-N)
passage, reading-3 - 2022-02-22 Placed on Calendar
- 2022-02-22 Read first time
reading-1 - 2022-02-22 Referred to Committee on Health, Welfare and Institutions
referral-committee - 2022-02-24 Reported from Health, Welfare and Institutions with substitute (20-Y 1-N)
committee-passage - 2022-02-24 Committee substitute printed 22106839D-H1
substitution - 2022-02-28 Read second time
reading-2 - 2022-02-28 Impact statement from DPB (SB300H1)
- 2022-03-01 Passed by for the day
- 2022-03-03 Read third time
reading-3 - 2022-03-03 Committee substitute agreed to 22106839D-H1
- 2022-03-03 Engrossed by House - committee substitute SB300H1
- 2022-03-03 Passed House with substitute (100-Y 0-N)
passage - 2022-03-03 VOTE: Passage (100-Y 0-N)
- 2022-03-07 House substitute agreed to by Senate (39-Y 0-N)
- 2022-03-07 Title replaced 22106839D-H1
- 2022-03-10 Enrolled
- 2022-03-10 Impact statement from DPB (SB300ER)
- 2022-03-10 Signed by President
- 2022-03-10 Signed by Speaker
- 2022-03-22 Enrolled Bill Communicated to Governor on March 22, 2022
- 2022-03-22 Governor's Action Deadline 11:59 p.m., April 11, 2022
- 2022-04-11 Approved by Governor-Chapter 513 (effective 1/1/23)
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/61d040ec-9222-4d8d-a46f-6d3ed9e63f7f. Confidence: reported (aggregated from official Virginia legislature records).